Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed Mar 14, 2024
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-03-12+46,250→ 175,801 total - Award
Stock Option (right to buy)
2024-03-12+92,500→ 92,500 totalExercise: $9.95Exp: 2034-03-12→ Common Stock (92,500 underlying)
Holdings
- 4,039(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-sixteenth of the RSUs shall vest on June 12, 2024 and each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F2]The securities are held directly by the reporting person's spouse.
- [F3]One forty-eighth of the shares subject to the option shall vest on April 12, 2024 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.